The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings. For the treatment of peptide-secreting enteroendocrine cells, most research has focused on developing peptide multi-agonists as most o...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Society of Lipid and Atherosclerosis
2023-09-01
|
| Edice: | Journal of Lipid and Atherosclerosis |
| Témata: | |
| On-line přístup: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.3.213&code=9992JLA&vmode=FULL |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|